Sided inhibition of glutamate transporter homologue reconstituted into liposomes reveals oriented kinetics of transport cycle. — ASN Events

Sided inhibition of glutamate transporter homologue reconstituted into liposomes reveals oriented kinetics of transport cycle. (#131)

Benjamin C McIlwain 1 , Robert J Vandenberg 1 , Renae M Ryan 1
  1. Transporter Biology Group, University of Sydney, Camperdown, NSW, Australia

The aspartate transporter from Pyrococcus horikoshii, GltPh, is a concentrative solute transporter homologous to human glutamate transporters. Glutamate transporters use steep gradients of Na+ to sequester glutamate within presynaptic neurons and glial cells to prevent toxic accumulation of glutamate at the excitatory synapse. X-ray crystallography provides structural details of GltPh, while functional data is obtained by reconstituting the transporter in liposomes.

There currently exists a collection of high-fidelity crystal structures that have captured GltPh in a variety of states representative of the transport cycle. These structures have revealed GltPh to be trimeric, with the binding site for aspartate held between two re-entrant hairpin loops (HP2 and HP1), the extracellular and (putative) intracellular gates, respectively (Boudker et al., 2007; Reyes et al., 2009). The final structure required to complete the conformational ensemble of GltPh is with substrate-bound and HP1 propped open, poised to release substrate.

When reconstituted into liposomes, GltPh distributes as a random population of inward- and outward-facing transporters, which can obscure subtle transporter kinetics. A novel approach using MTS-reagent thiol modification (Tsai et al., 2012) has allowed the development of sided-inhibition of GltPh to investigate oriented kinetics of the transporter. Using this strategy, the inhibitor profile of a variety of N-modified aspartate analogues has been characterised and are shown to have preference for the inward-facing orientation of GltPh. This preference for the ‘intracellular’ binding site allows us to probe the molecular determinants of inhibitor affinity and may provide an avenue to ‘lock’ the transporter in a state amenable to X-ray crystallography.

  1. Boudker O, Ryan RM, Yernool D, Shimamoto K, Gouaux E (2007). Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature 445(7126): 387-393.
  2. Reyes N, Ginter C, Boudker O (2009). Transport mechanism of a bacterial homologue of glutamate transporters. Nature 462(7275): 880-885.
  3. Tsai M-F, Fang Y, Miller C (2012). Sided Functions of an Arginine–Agmatine Antiporter Oriented in Liposomes. Biochemistry 51(8): 1577-1585.